Study: Omicron evades some but not all monoclonal antibodies
Por um escritor misterioso
Descrição
Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, researchers reported Jan. 19 in the journal Nature Medicine.
Omicron may not evade all monoclonal antibodies, lab study suggests - Express Pharma
Monoclonal antibodies can't keep Omicron variant in check, 2021-12-27
monoclonal antibodies, VUMC Reporter
Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates - WSJ
Broadly neutralizing antibody could fight new COVID-19 variants - Boston Children's Answers
COVID-19 breakthrough infections and the omicron variant: What to know now
Omicron variant evolution on vaccines and monoclonal antibodies
Monoclonal antibodies lock down SARS-CoV-2 spike: Trends in Immunology
New Omicron subvariant BQ.1.1 resistant to al
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
Viruses, Free Full-Text
New study suggests most monoclonal antibody treatments are ineffective against Omicron SARS-CoV-2 variant
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies - eBioMedicine
